Resources

  1. 1

    Posted on: May 18, 2016 - Journal articles

    The oral cholera vaccine Shanchol™ when stored at elevated temperatures maintains the safety and immunogenicity profile in Bangladeshi participants.


    Article published in Vaccine on 18-March-2016 by Saha A et al.  ABSTRACT BACKGROUND: The oral cholera vaccine (OCV), Shanchol™ has shown protective efficacy lasting up to 5 years, however, requirement for a cold chain limits its use in resource poor ...

  2. 2

    Posted on: May 5, 2016 - Journal articles

    Efficacy of a Single-Dose, Inactivated Oral Cholera Vaccine in Bangladesh


    Article published in The New England Journal of Medicine on 5-May-2016 by Qadri F. et al.   ABSTRACT BACKGROUND:  A single-dose regimen of the current killed oral cholera vaccines that have been prequalified by the World Health Organization would make ...

  3. 3

    Posted on: August 23, 2014 -

    Herd immunity conferred by killed oral cholera vaccines in Bangladesh: a reanalysis


    Article published in The Lancet on 02-Jul-2005 by Ali M et al. BACKGROUND: Decisions about the use of killed oral cholera vaccines, which confer moderate levels of direct protection to vaccinees, can depend on whether the vaccines also provide indirect ...

  4. 4

    Posted on: August 23, 2014 -

    Field trial of oral cholera vaccines in Bangladesh: results from three-year follow-up


    Article published in The Lancet on 03-Feb-1990 by Clemens JD et al. ABSTRACT: The protective efficacy (PE) of B subunit killed whole-cell (BS-WC) and killed whole-cell-only (WC) oral cholera vaccines was assessed in a randomised double-blind field trial ...

  5. 5

    Posted on: August 1, 2012 - Journal articles

    Antigen-Specific Memory T Cell Responses after Vaccination with an Oral Killed Cholera Vaccine in Bangladeshi Children and Comparison to Responses in Patients with Naturally Acquired Cholera


    Article published in Clinical and Vaccine Immunology in August 2012 by Arifuzzaman M. et al. ABSTRACT Young children, older children, and adults develop comparable levels and durations of immunity following cholera. In comparison, young children receiving ...

  6. 6

    Posted on: July 24, 2012 - Journal articles

    Safety of the Recombinant Cholera Toxin B Subunit, Killed Whole-Cell (rBS-WC) Oral Cholera Vaccine in Pregnancy


    Article published in PLOS Neglected Tropical Diseases on 24-July-2012 by Hashim R. et al ABSTRACT Introduction: Mass vaccinations are a main strategy in the deployment of oral cholera vaccines. Campaigns avoid giving vaccine to pregnant women because of ...

  7. 7

    Posted on: May 1, 2012 - Journal articles

    Memory B Cell and Other Immune Responses in Children Receiving Two Doses of an Oral Killed Cholera Vaccine Compared to Responses following Natural Cholera Infection in Bangladesh


    Article published by Clinical and Vaccine Immunology in May-2012 by Leung DT. et al. ABSTRACT Current oral cholera vaccines induce lower protective efficacy and shorter duration of protection against cholera than wild-type infection provides, and this ...

  8. 8

    Posted on: October 26, 2011 - Journal articles

    Safety and immunogenicity study of a killed bivalent (O1 and O139) whole-cell oral cholera vaccine Shanchol, in Bangladeshi adults and children as young as 1 year of age


    Article published by Vaccine on 26-October-2011 by Saha A. et al. ABSTRACT Background:Safety and immunogenicity study of an oral, killed, bivalent whole-cell, cholera vaccine, Shanchol was carried out in Bangladeshi participants. This study was conducted ...